Scientists dig up new evidence linking GSK's Pandemrix with narcolepsy

A team of Stanford University scientists think they have found a potential reason why GlaxoSmithKline's ($GSK) now-withdrawn flu shot Pandemrix was associated with a spike in narcolepsy cases. In a study published in Science Translational Medicine, the researchers said a protein contained in the H1N1 virus was found in high amounts in GSK's vaccine. A Novartis ($NVS) jab also used in the 2009/2010 swine flu pandemic contained much lower levels of the same protein, they said. More from FierceVaccines